Fatigue in neurological disorders

[1]  M. Trimble.  Behavioral Neurology, 4th ed. , 2004 .

[2]  A. Zenzola,et al.  Fatigue in Parkinson’s disease , 2003, Neurological Sciences.

[3]  N. Secher,et al.  Cerebral Metabolism is Influenced by Muscle Ischaemia During Exercise in Humans , 2003, Experimental physiology.

[4]  E. Tolosa,et al.  Cognitive effects of unilateral posteroventral pallidotomy: A 4‐year follow‐up study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[5]  E. D. de Haan,et al.  Cognitive functioning in patients with a small infarct in the brainstem , 2003, Journal of the International Neuropsychological Society.

[6]  B. Condon,et al.  Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome , 2003, Neuroreport.

[7]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[8]  T. Scammell,et al.  The neurobiology, diagnosis, and treatment of narcolepsy , 2003, Annals of neurology.

[9]  J. Hajnal,et al.  Relative increase in choline in the occipital cortex in chronic fatigue syndrome , 2002, Acta psychiatrica Scandinavica.

[10]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[11]  M. Rupp,et al.  Modafinil in treatment of fatigue in multiple sclerosis , 2002, Journal of Neurology.

[12]  Peter Campbell,et al.  The Madness of Adam and Eve: How Schizophrenia Shaped Humanity David Horrobin The Madness of Adam and Eve: How Schizophrenia Shaped Humanity Corgi Books £8.99;346pps055299930X055299930X , 2002 .

[13]  N. Ling,et al.  Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. , 2002, The Journal of pharmacology and experimental therapeutics.

[14]  R. Yehuda.  Current status of cortisol findings in post-traumatic stress disorder. , 2002, The Psychiatric clinics of North America.

[15]  E. Glader,et al.  Poststroke Fatigue: A 2-Year Follow-Up Study of Stroke Patients in Sweden , 2002, Stroke.

[16]  G. Griebel,et al.  Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Felix.  Insights from Mouse Models of Absence Epilepsy into Ca2+ Channel Physiology and Disease Etiology , 2002, Cellular and Molecular Neurobiology.

[18]  G. Scotti,et al.  Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis , 2002, NeuroImage.

[19]  I. Appollonio,et al.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[20]  T. Gordon,et al.  Effect of exercise on stability of chronically enlarged motor units , 2002, Muscle & nerve.

[21]  H. Nagaraja,et al.  Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[22]  R. Haller,et al.  Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy , 2002, Annals of neurology.

[23]  M. Andersen,et al.  Exercise and multiple sclerosis: physiological, psychological, and quality of life issues. , 2001, The Journal of sports medicine and physical fitness.

[24]  P. Whiting,et al.  Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. , 2001, JAMA.

[25]  David H. Miller,et al.  Fatigue is not associated with raised inflammatory markers in multiple sclerosis , 2001, Neurology.

[26]  Julien Bogousslavsky,et al.  Fatigue after Stroke: A Major but Neglected Issue , 2001, Cerebrovascular Diseases.

[27]  C. Rice,et al.  Quadriceps muscle function and fatigue in women with Addison's disease , 2001, Muscle & nerve.

[28]  Robert L. Royall,et al.  Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. , 2001, Archives of general psychiatry.

[29]  J. Oger,et al.  Potassium channel antibodies in two patients with reversible limbic encephalitis , 2001, Annals of neurology.

[30]  P. Sullivan,et al.  A Twin Study of Chronic Fatigue , 2001, Psychosomatic medicine.

[31]  Filippo Martinelli-Boneschi,et al.  Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary Movement—EEG Evidence , 2001, NeuroImage.

[32]  G. Comi,et al.  Physiopathology and treatment of fatigue in multiple sclerosis , 2001, Journal of Neurology.

[33]  Susan K. Johnson,et al.  Longitudinal Assessment of Neuropsychological Functioning, Psychiatric Status, Functional Disability and Employment Status in Chronic Fatigue Syndrome , 2001, Applied neuropsychology.

[34]  J. Pearn.  Neurology of ciguatera , 2001, Journal of neurology, neurosurgery, and psychiatry.

[35]  L. E. Elkins,et al.  Fatigue and declines in cognitive functioning in multiple sclerosis , 2000, Neurology.

[36]  A. Chaudhuri,et al.  Fatigue and basal ganglia , 2000, Journal of the Neurological Sciences.

[37]  R. L. Bruno,et al.  Word finding difficulty as a post-polio sequelae. , 2000, American journal of physical medicine & rehabilitation.

[38]  R. Blakely,et al.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. , 2000, The New England journal of medicine.

[39]  R I Grossman,et al.  Total brain N-acetylaspartate , 2000, Neurology.

[40]  A. Tomoda,et al.  Chronic fatigue syndrome in childhood , 2000, Brain and Development.

[41]  G. Alarcón,et al.  Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia? , 1999, Arthritis and rheumatism.

[42]  P. Schmitz,et al.  Fatigue in immune-mediated polyneuropathies , 1999, Neurology.

[43]  T. Munsat,et al.  A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome , 1999, Neurology.

[44]  H. Fankhauser,et al.  Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. , 1999, Journal of neurosurgery.

[45]  O. Sharma.  Fatigue and sarcoidosis. , 1999, The European respiratory journal.

[46]  J. Stewart,et al.  Orthostatic Intolerance in Adolescent Chronic Fatigue Syndrome , 1999, Pediatrics.

[47]  A. Algra,et al.  Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life , 1998, Journal of neurology, neurosurgery, and psychiatry.

[48]  R. L. Bruno,et al.  Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology? , 1998, The American journal of medicine.

[49]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[50]  J. Rothwell,et al.  An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. , 1998, Brain : a journal of neurology.

[51]  R. Poland,et al.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. , 1998, Archives of neurology.

[52]  B. McEwen.  Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.

[53]  A. McComas,et al.  Early and late losses of motor units after poliomyelitis. , 1997, Brain : a journal of neurology.

[54]  W. Ammann,et al.  Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue , 1997, Neurology.

[55]  Susan K. Johnson,et al.  Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[56]  J C Rothwell,et al.  An electrophysiological study of the mechanism of fatigue in multiple sclerosis. , 1997, Brain : a journal of neurology.

[57]  E. Kandel,et al.  Essentials of Neural Science and Behavior , 1996 .

[58]  R. L. Bruno,et al.  Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue. , 1996, American journal of physical medicine & rehabilitation.

[59]  R. Adams,et al.  Principles of Neurology , 1996 .

[60]  M. Latash,et al.  Myogenic and Central Neurogenic Factors in Fatigue in Multiple Sclerosis , 1996, Multiple sclerosis.

[61]  J. Dambrosia,et al.  A Double‐Blind, Placebo‐Controlled Trial of High‐Dose Prednisone for the Treatment of Post‐Poliomyelitis Syndrome , 1995, Annals of the New York Academy of Sciences.

[62]  R. Sapolsky,et al.  Pathophysiology of a Central Cause, of Post‐Polio Fatigue a , 1995, Annals of the New York Academy of Sciences.

[63]  J. Dambrosia,et al.  A Double‐Blind, Placebo‐Controlled, Trial of Amantadine for the Treatment, of Fatigue in Patients with the, Post‐Polio Syndrome , 1995, Annals of the New York Academy of Sciences.

[64]  T. Rummans,et al.  Postural tachycardia syndrome (POTS). , 1995, Neurology.

[65]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[66]  W. Wayt Gibbs.  More fun than a root canal. , 1993, Scientific American.

[67]  J. DeLuca,et al.  The neuropsychology of post-polio fatigue. , 1993, Archives of physical medicine and rehabilitation.

[68]  R. Roos,et al.  Diurnal effects of motor activity and fatigue in Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[69]  T. Birk,et al.  Poliomyelitis and the post-polio syndrome: exercise capacities and adaptation--current research, future directions, and widespread applicability. , 1993, Medicine and science in sports and exercise.

[70]  T. Dinan.  Studying brain receptor function: a neuroendocrine approach , 1993, Irish Journal of Psychological Medicine.

[71]  B. Weinshenker,et al.  A double‐blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis , 1992, Neurology.

[72]  P Sandroni,et al.  'Fatigue' in patients with multiple sclerosis. Motor pathway conduction and event-related potentials. , 1992, Archives of neurology.

[73]  D. Eckland,et al.  Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. , 1992, Endocrinology.

[74]  M. Taussig.  The Nervous System , 1991 .

[75]  S. Olejnik,et al.  Effect of treatment and noncompliance on post-polio sequelae. , 1991, Orthopedics.

[76]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[77]  B. Weinshenker,et al.  A Randomized Controlled Trial of Amantadine in Fatigue Associated With Multiple Sclerosis , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[78]  T. J. Murray,et al.  Amantadine Therapy for Fatigue in Multiple Sclerosis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[79]  T D Noakes,et al.  Hypothalamic dysfunction in overtrained athletes. , 1985, The Journal of clinical endocrinology and metabolism.

[80]  G. Kraft,et al.  Symptomatic fatigue in multiple sclerosis. , 1984, Archives of physical medicine and rehabilitation.

[81]  Adrian M. S. Piper.  A Distinction without a Difference , 1982 .

[82]  Zeliha Ünlü.  Myotonic dystrophy , 1981, The Ulster Medical Journal.

[83]  L. Brain.  The Nervous System , 1963, Nature.

[84]  J. Lefaucheur,et al.  [Pathophysiology and treatment of fatigue in multiple sclerosis]. , 2006, Revue neurologique.

[85]  Lauren B. Krupp,et al.  Fatigue in Multiple Sclerosis , 2003, CNS drugs.

[86]  David F. Horrobin,et al.  The Madness of Adam and Eve: How Schizophrenia Shaped Humanity , 2002 .

[87]  A. Chaudhuri,et al.  Neurological Dysfunction in Chronic Fatigue Syndrome , 2000 .

[88]  R. Jordan,et al.  Treatments for fatigue in multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.

[89]  R. L. Bruno.  Paralytic vs. "nonparalytic" polio: distinction without a difference? , 2000, American journal of physical medicine & rehabilitation.

[90]  F. Nollet,et al.  A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. , 2000, Neurology.

[91]  T. Dinan,et al.  The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis. , 1999, Functional neurology.

[92]  C. U. M. Smith,et al.  Elements of molecular neurobiology , 1989 .

[93]  B. Giesser.  Multiple sclerosis. Current concepts in management. , 1985, Drugs.

[94]  D. Denny-Brown.  The basal ganglia and their relation to disorders of movement , 1962 .